10X GENOMICS INC's ticker is TXG and the CUSIP is 88025U109. A total of 230 filers reported holding 10X GENOMICS INC in Q3 2022. The put-call ratio across all filers is 0.78 and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $199,980 | -7.2% | 4,848 | +25.6% | 0.03% | -8.8% |
| Q2 2023 | $215,598 | +7.2% | 3,861 | 0.0% | 0.03% | 0.0% |
| Q1 2023 | $201,044 | +43.4% | 3,861 | +0.3% | 0.03% | +30.8% |
| Q4 2022 | $140,221 | +28.6% | 3,848 | +0.2% | 0.03% | +13.0% |
| Q3 2022 | $109,000 | -50.2% | 3,840 | -20.7% | 0.02% | -51.1% |
| Q2 2022 | $219,000 | -40.5% | 4,840 | 0.0% | 0.05% | -30.9% |
| Q1 2022 | $368,000 | +1433.3% | 4,840 | +2869.3% | 0.07% | +1260.0% |
| Q4 2021 | $24,000 | – | 163 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management II, LLC | 1,753,528 | $133,391,000 | 100.00% |
| Foresite Capital Management I, LLC | 750,000 | $57,053,000 | 99.71% |
| 12 West Capital Management LP | 2,518,500 | $191,582,000 | 11.65% |
| Meritech Capital Associates V L.L.C. | 1,336,253 | $101,649,000 | 9.59% |
| Blue Water Life Science Advisors, LP | 211,917 | $16,121,000 | 7.65% |
| Decheng Capital Management III (Cayman), LLC | 303,984 | $23,124,000 | 7.09% |
| FINANCIAL CONSULATE, INC | 154,942 | $11,786,000 | 4.53% |
| Evolutionary Tree Capital Management, LLC | 54,128 | $4,118,000 | 2.86% |
| HARVARD MANAGEMENT CO INC | 186,143 | $14,160,000 | 1.43% |
| Brown Capital Management | 1,663,469 | $126,540,000 | 1.26% |